Status: Recruiting
A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
The aim of this study is to evaluate the safety, reactogenicity, and immune response of the different formulations of the investigational RSV/hMPV combination vaccine and investigational hMPV vaccine in younger and older adults.
Participants needed: 1,456
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: GlaxoSmithKlineUpdated: Aug 20, 2026Locations: 4
Eligibility criteria
Written informed consent obtained from the participant prior to performance of a... [+9]
History of any reaction or hypersensitivity likely to be exacerbated by any comp... [+31]